Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases.

ABSTRACT:

SUBMITTER: Chiang TP 

PROVIDER: S-EPMC8440413 | biostudies-literature | 2021 Oct

REPOSITORIES: biostudies-literature